Donahey says Octogen line will not die
A UDRP panellist who first adopted the so-called Octogen line of thinking on bad faith has insisted the doctrine will be revived despite receiving another blow
In the original 2009 case, Octogen Pharmacal Company v Octogen e-Solutions, Scott Donahey argued that bad faith registration could be found retrospectively if the domain was used abusively.
Donahey broke with UDRP consensus that said both registration and use of...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.